NewcelX Ltd. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-12-22: Form 6-K; Period of report 2021-12-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152865-6k_nlspharmaceutics.htm.
- 2021-12-16: Form 6-K; Period of report 2021-12-15; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152430-6k_nlspharma.htm.
- 2021-12-15: Form 6-K; Period of report 2021-12-15; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152430-6k_nlspharma.htm.
- 2021-12-14: Form 6-K; Period of report 2021-12-14; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152341-6k_nlspharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-12-22 | 6-K | 2021-12-21 | REPORT OF FOREIGN PRIVATE ISSUER | ea152865-6k_nlspharmaceutics.htm |
| 2021-12-16 | 6-K | 2021-12-15 | REPORT OF FOREIGN PRIVATE ISSUER | ea152430-6k_nlspharma.htm |
| 2021-12-15 | 6-K | 2021-12-15 | REPORT OF FOREIGN PRIVATE ISSUER | ea152430-6k_nlspharma.htm |
| 2021-12-14 | 6-K | 2021-12-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea152341-6k_nlspharma.htm |
| 2021-11-30 | 6-K | 2021-11-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea151499-6k_nlspharma.htm |
| 2021-11-23 | 6-K | 2021-11-23 | REPORT OF FOREIGN PRIVATE ISSUER | ea151222-6k_nlspharma.htm |
| 2021-11-18 | 6-K | 2021-11-18 | REPORT OF FOREIGN PRIVATE ISSUER | ea150982-6k_nlspharm.htm |
| 2021-11-01 | 6-K | 2021-11-01 | REPORT OF FOREIGN PRIVATE ISSUER | ea149622-6k_nlspharma.htm |
| 2021-10-26 | 6-K | 2021-10-26 | REPORT OF FOREIGN PRIVATE ISSUER | ea149342-6k_nlspharmaceutics.htm |
| 2021-10-14 | 6-K | 2021-10-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea148843-6k_nlspharma.htm |
| 2021-09-28 | 6-K | 2021-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea147969-6k_nlspharma.htm |
| 2021-09-28 | 6-K | 2021-09-28 | REPORT OF FOREIGN PRIVATE ISSUER | ea148010-6k_nlspharma.htm |
| 2021-09-14 | 6-K | 2021-09-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea147367-6k_nlspharma.htm |
| 2021-08-19 | 6-K | 2021-08-19 | CURRENT REPORT | ea146152-6k_nlspharma.htm |
| 2021-07-19 | 6-K | 2021-07-19 | REPORT OF FOREIGN PRIVATE ISSUER | ea144393-6k_nlspharm.htm |
| 2021-07-16 | 6-K | 2021-07-15 | CURRENT REPORT OF PRIVATE ISSUER | ea144297-6k_nlspharm.htm |
| 2021-07-06 | 6-K | 2021-07-06 | REPORT OF FOREIGN PRIVATE ISSUER | ea143744-6k_nlspharma.htm |
| 2021-06-17 | 6-K | 2021-06-17 | REPORT OF FOREIGN PRIVATE ISSUER | ea142886-6k_nlspharmaceutics.htm |
| 2021-05-25 | 6-K | 2021-05-25 | REPORT OF FOREIGN PRIVATE ISSUER | ea141681-6k_nlspharmaceu.htm |
| 2021-05-14 | 6-K | 2021-05-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea140776-6k_nlspharmaceutics.htm |
| 2021-04-06 | 6-K | 2021-04-06 | REPORT OF FOREIGN PRIVATE ISSUER | ea139080-6k_nlspharma.htm |
| 2021-04-05 | 6-K | 2021-04-05 | REPORT OF FOREIGN PRIVATE ISSUER | ea138964-6k_nlspharmaceutics.htm |
| 2021-03-12 | 6-K | 2021-03-12 | REPORT OF FOREIGN PRIVATE ISSUER | ea137558-6k_nlspharma.htm |
| 2021-03-10 | 6-K | 2021-03-10 | REPORT OF FOREIGN PRIVATE ISSUER | ea137211-6k_nlspharma.htm |
| 2021-03-01 | 6-K | 2021-03-01 | REPORT OF FOREIGN PRIVATE ISSUER | ea136707-6k_nlspharma.htm |
| 2021-02-09 | 6-K | 2021-02-08 | REPORT OF FOREIGN PRIVATE ISSUER | ea134898-6k_nlsphar.htm |
| 2021-02-02 | 6-K | 2021-02-02 | REPORT OF FOREIGN PRIVATE ISSUER | ea134404-6k_nlspharmaceutics.htm |
| 2021-01-29 | 6-K | 2021-01-29 | REPORT OF FOREIGN PRIVATE ISSUER | ea134203-6k_nlspharma.htm |